ALISSA KINCEL: Open Payments
NPI 1992492524 · KENNETT SQUARE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$905 in 35 payments from 10 companies in 2025. Trend: 2023 $340 · 2024 $509 · 2025 $905
Food & beverage: $905
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 10 | $208 |
| Novartis Pharmaceuticals Corporation | 11 | $181 |
| E.R. Squibb & Sons, L.L.C. | 1 | $134 |
| PFIZER INC. | 5 | $116 |
| BridgeBio Pharma, Inc. | 1 | $94 |
| Esperion Therapeutics, Inc. | 3 | $68 |
| SCPHARMACEUTICALS INC. | 1 | $35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $31 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
Products named: REPATHA, LEQVIO, Attruby, NEXLETOL, VYNDAQEL, ELIQUIS, FUROSCIX, JARDIANCE.
Industry payments across PA — which companies pay providers there.
